Suppr超能文献

立体选择性方法开发与验证:同时萃取-手性衍生化法测定人尿液中苯丙胺类兴奋剂及其代谢物浓度

Stereoselective method development and validation for determination of concentrations of amphetamine-type stimulants and metabolites in human urine using a simultaneous extraction-chiral derivatization approach.

机构信息

Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kubang Kerian, Kelantan, Malaysia.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Jan 1;879(1):8-16. doi: 10.1016/j.jchromb.2010.10.037. Epub 2010 Nov 24.

Abstract

Amphetamine-type stimulants (ATS) are a group of chiral amine drugs which are commonly abused for their sympathomimetic and stimulant properties. ATS are extensively metabolised by hepatic cytochrome P450 enzymes. As metabolism of ATS has been shown to be highly stereospecific, stereoselective analytical methods are essential for the quantitative determination of ATS concentrations for both in vivo and in vitro studies of ATS metabolism. This paper describes a new stereoselective method for the simultaneous determination of amphetamine (AM), methamphetamine (MA), 3,4-methylenedioxymethamphetamine (MDMA), 3,4-methylenedioxyamphetamine (MDA), 4-hydroxy-3-methoxymethamphetamine (HMMA), 4-hydroxy-3-methoxyamphetamine (HMA), 3,4-hydroxymethamphetamine (HHMA) and 3,4-hydroxyamphetamine (HHA) in human urine samples validated according to the United States Food and Drug Administration guidelines. In this method, analytes are simultaneously extracted and derivatized with R-(-)-α-methoxy-α-(trifluoromethyl)phenylacetyl chloride (R-MTPCl) as the chiral derivatization reagent. Following this, the analytes were subjected to a second derivatization with N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) which targets the hydroxyl groups present in HMMA, HMA, HHMA and HHA. The derivatized analytes were separated and quantified using gas chromatography-mass spectrometry (GC-MS). The method was evaluated according to the established guidelines for specificity, linearity, precision, accuracy, recovery and stability using a five-day protocol. Intra-day precision ranged from 0.89 to 11.23% RSD whereas inter-day precision was between 1.03 and 12.95% RSD. Accuracy values for the analytes ranged from -5.29% to 13.75%. Limits of quantitation were 10 μg/L for AM, MA, MDMA, HMA and HMMA and 2μg/L for MDA, HMA and HHA. Recoveries and stability values were also within accepted values. The method was applied to authentic ATS-positive samples.

摘要

苯丙胺类兴奋剂(ATS)是一组手性胺类药物,因其拟交感和兴奋剂特性而被广泛滥用。ATS 广泛地被肝细胞色素 P450 酶代谢。由于 ATS 的代谢已被证明具有高度立体特异性,因此对于 ATS 代谢的体内和体外研究的 ATS 浓度的定量测定,立体选择性分析方法是必不可少的。本文描述了一种新的立体选择性方法,用于同时测定尿液样品中的苯丙胺(AM)、甲基苯丙胺(MA)、3,4-亚甲基二氧基甲基苯丙胺(MDMA)、3,4-亚甲基二氧基苯丙胺(MDA)、4-羟基-3-甲氧基甲基苯丙胺(HMMA)、4-羟基-3-甲氧基苯丙胺(HMA)、3,4-羟甲基苯丙胺(HHMA)和 3,4-羟苯丙胺(HHA),该方法符合美国食品和药物管理局的指导原则。在该方法中,分析物同时用 R-(-)-α-甲氧基-α-(三氟甲基)苯乙酰氯(R-MTPCl)作为手性衍生试剂进行提取和衍生化。然后,用 N-甲基-N-三甲基硅基三氟乙酰胺(MSTFA)对存在于 HMMA、HMA、HHMA 和 HHA 中的羟基进行第二次衍生化。衍生化的分析物使用气相色谱-质谱(GC-MS)进行分离和定量。使用五天方案,根据特异性、线性、精密度、准确度、回收率和稳定性的既定准则对该方法进行了评估。日内精密度范围为 0.89%至 11.23%RSD,而日间精密度为 1.03%至 12.95%RSD。分析物的准确度值范围为-5.29%至 13.75%。AM、MA、MDMA、HMA 和 HMMA 的定量限为 10μg/L,MDA、HMA 和 HHA 的定量限为 2μg/L。回收率和稳定性值也在可接受范围内。该方法应用于真实的 ATS 阳性样本。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验